Answers are grounded in this paper and cite their sources.
cell-based relative potency assay for an AAV vector, which was used to evaluate lot-to-lot consistency, stability, and comparability following manufacturing changes and to successfully launch Luxturna, the first gene therapy approved in the US for a genetic disease.
No takes yet. Share an insight, caveat, or question.
High et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: